Latest filing published 02 Mar 2018 for PetLife Pharmaceuticals, Inc..
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ralph T. Salvagno: trading record in brief
All filings by Ralph T. Salvagno on record concern PetLife Pharmaceuticals, Inc. Between 29 December 2015 and 17 August 2017, the trades on record add up to 8 filings.
No open-market sale appears; the market trades are 4 purchases worth €525k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants.
In size, the median ticket on the buying side is €141k.
The latest filing, published on 2 March 2018, reports a transaction in PetLife Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 3,513 days ago, on 27 March 2017. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ralph T. Salvagno
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,250,000 sharesCommon StockSEC:0001493152-18-002844:0
- 1,250,000 sharesSeries A Preferred StockSEC:0001493152-18-002844:1
- 5,000,000 shares@ US$0.064.6% of flowCommon StockSEC:0001493152-18-002844:2
- 100,000 shares@ US$0.25Common StockSEC:0001493152-17-002852:0Canonical exit: 28 Mar 2016 (T+90)
- 250,000 shares@ US$0.64Common StockSEC:0001493152-17-002852:1Canonical exit: 12 May 2016 (T+90)
- 540,000 shares@ US$0.46Common StockSEC:0001493152-17-002852:2Canonical exit: 12 May 2016 (T+90)
- 11,160,000 shares@ US$0.5095.4% of flowCommon StockSEC:0001493152-17-002852:4
7 of 7 declarations